Conference Coverage

PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan


 

REPORTING FROM ACC 19

Pages

Recommended Reading

Forget what you learned about infective endocarditis
MDedge Cardiology
Five pitfalls in optimizing medical management of HFrEF
MDedge Cardiology
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
MDedge Cardiology
FDA approves new valsartan generic
MDedge Cardiology
MitraClip improves survival and health status for at least 2 years
MDedge Cardiology
FDA: Programmable heart failure device approved
MDedge Cardiology
30-day readmissions after STEMI with cardiogenic shock 13%
MDedge Cardiology
Look for alcohol septal ablation in the next HOCM guideline
MDedge Cardiology
Novel percutaneous therapy for HOCM in development
MDedge Cardiology
Clinicians, CMS confer over heart failure–readmission penalty
MDedge Cardiology

Related Articles